Skip to main content

Table 3 Cause of death of 45 patients with rheumatic disease and cancer

From: Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis

 

RD

Cancer

Cause of death

Stage

ECOGa

Comorbidityb

1

DM/PM

Breast

Cancer progression

2

1

1

2

DM/PM

Gastric

Cancer progression

4

0

0

3

DM/PM

Lung

Cancer progression

1

0

0

4

DM/PM

Lung

Cancer progression

1

0

1

5

DM/PM

Lung

Cancer progression

2

2

1

6

DM/PM

Lung

Cancer progression

2

2

0

7

DM/PM

Lung

Cancer progression

3

2

0

8

DM/PM

Lung

Cancer progression

NA

0

0

9

RA

Breast

Cancer progression

2

0

2

10

RA

Breast

Cancer progression

4

1

0

11

RA

Breast

Congestive Heart failure

1

0

1

12

RA

Breast

Old age

2

0

2

13

RA

Colon

Cancer progression

1

1

1

14

RA

Colon

Cancer progression

3

2

2

15

RA

Colon

Cancer progression

4

1

2

16

RA

Lung

Cancer progression

1

0

0

17

RA

Lung

Cancer progression

1

0

0

18

RA

Lung

Cancer progression

1

0

0

19

RA

Lung

Cancer progression

2

1

2

20

RA

Lung

Cancer progression

2

0

0

21

RA

Lung

Cancer progression

2

0

1

22

RA

Lung

Cancer progression

3

2

1

23

RA

Lung

Cancer progression

3

0

1

24

RA

Lung

Cancer progression

3

0

1

25

RA

Lung

Cancer progression

3

1

2

26

RA

Lung

Cancer progression

4

1

0

27

RA

Lung

Cancer progression

4

2

0

28

RA

Lung

Cancer progression

4

0

0

29

RA

Lung

Cancer progression

4

1

1

30

RA

Lung

Cancer progression

4

2

2

31

RA

Lung

Cancer progression

4

2

1

32

RA

Lung

Cancer progression

4

1

0

33

RA

Lung

Cancer progression

4

2

1

34

RA

Lung

Cancer progression

4

0

0

35

RA

Lung

Cancer progression

4

1

0

36

RA

Lung

Cancer progression

4

0

2

37

RA

Lung

Cancer progression

NA

1

0

38

SLE

Breast

Cancer progression

4

1

0

39

SLE

Colon

Cancer progression

1

0

2

40

SSc

Colon

ILD aggrevation

3

1

2

41

SSc

Lung

Cancer progression

4

1

2

42

SSc

Lung

Cancer progression

4

2

1

43

SSc

Lung

Cancer progression

4

1

0

44

SSc

Lung

Cancer progression

4

0

0

45

SSc

Lung

Cancer progression

NA

2

2

  1. F female, NA not available, RD rheumatic disease, DM dermatomyositis, PM polymyositis, RA rheumatoid arthritis, SLE systemic lupus erythematosus, SSc systemic sclerosis
  2. aAn Eastern Cooperative Oncology Group (ECOG) performance status
  3. bThe Charlson comorbidity index was adjusted for connective tissue disease and cancer